These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2152918)
21. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites. Knaus HG; Moshammer T; Kang HC; Haugland RP; Glossmann H J Biol Chem; 1992 Feb; 267(4):2179-89. PubMed ID: 1310311 [TBL] [Abstract][Full Text] [Related]
22. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle. Feron O; Wibo M; Christen MO; Godfraind T Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732 [TBL] [Abstract][Full Text] [Related]
23. [3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channel. Rampe D; Kim HS; Lacerda AE; Birnbaumer L; Brown AM Biochem Biophys Res Commun; 1990 Jun; 169(3):825-31. PubMed ID: 2163635 [TBL] [Abstract][Full Text] [Related]
24. Volatile anesthetics inhibit dihydropyridine binding to malignant hyperthermia-susceptible and normal pig skeletal muscle membranes. Louis CF; Roghair T; Mickelson JR Anesthesiology; 1994 Mar; 80(3):618-24. PubMed ID: 8141457 [TBL] [Abstract][Full Text] [Related]
25. Binding of dihydropyridine calcium antagonists to membranes from human skeletal muscle. Krizanová O; Orlický J; Zachar J Gen Physiol Biophys; 1988 Jun; 7(3):324-7. PubMed ID: 2456251 [No Abstract] [Full Text] [Related]
26. Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor. Sharp AH; Imagawa T; Leung AT; Campbell KP J Biol Chem; 1987 Sep; 262(25):12309-15. PubMed ID: 3040737 [TBL] [Abstract][Full Text] [Related]
27. Modulation of dihydropyridine-sensitive gastric mucosal calcium channels by GM1-ganglioside. Slomiany BL; Liu J; Fekete Z; Yao P; Slomiany A Int J Biochem; 1992 Aug; 24(8):1289-94. PubMed ID: 1322845 [TBL] [Abstract][Full Text] [Related]
28. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Striessnig J; Murphy BJ; Catterall WA Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10769-73. PubMed ID: 1660150 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. Kwan YW; Bangalore R; Lakitsh M; Glossmann H; Kass RS J Mol Cell Cardiol; 1995 Jan; 27(1):253-62. PubMed ID: 7760349 [TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibody identifies a 200-kDa subunit of the dihydropyridine-sensitive calcium channel. Morton ME; Froehner SC J Biol Chem; 1987 Sep; 262(25):11904-7. PubMed ID: 2442152 [TBL] [Abstract][Full Text] [Related]
31. Photoaffinity labeling of the calcium channel antagonist receptor in the heart of the cardiomyopathic hamster. Kuo TH; Johnson DF; Tsang W; Wiener J Biochem Biophys Res Commun; 1987 Nov; 148(3):926-33. PubMed ID: 2446613 [TBL] [Abstract][Full Text] [Related]
32. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations. Ptasienski J; McMahon KK; Hosey MM Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972 [TBL] [Abstract][Full Text] [Related]
33. The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+ channel. Purification and subunit composition. Borsotto M; Barhanin J; Fosset M; Lazdunski M J Biol Chem; 1985 Nov; 260(26):14255-63. PubMed ID: 2997201 [TBL] [Abstract][Full Text] [Related]
34. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery. Matlib MA Am J Cardiol; 1989 Nov; 64(17):51I-57I. PubMed ID: 2530885 [TBL] [Abstract][Full Text] [Related]
35. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker. Suh-Kim H; Wei X; Birnbaumer L Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365 [TBL] [Abstract][Full Text] [Related]
36. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines. Reynolds IJ; Snowman AM; Snyder SH J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067 [TBL] [Abstract][Full Text] [Related]
37. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells. Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351 [TBL] [Abstract][Full Text] [Related]
38. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells. Kunze DL; Hamilton SL; Hawkes MJ; Brown AM Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436 [TBL] [Abstract][Full Text] [Related]
39. Dihydropyridine-sensitive Ca2+ channel in aneurally cultured human muscles. Relationship between high-affinity binding site and inhibition of calcium uptake. Desnuelle C; Askanas V; Engel WK FEBS Lett; 1988 Mar; 230(1-2):95-100. PubMed ID: 2450788 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of dihydropyridine-sensitive calcium channels by the plant alkaloid ryanodine. Valdivia HH; Coronado R FEBS Lett; 1989 Feb; 244(2):333-7. PubMed ID: 2537759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]